Ontrak Health Demonstrates Significant Improvement in Members’ Quality of Life from ReQoL Mental Health Assessment

Company Contact:
Brandon LaVerne
Chief Executive Officer
blaverne@ontrakhealth.com

Investor Relations:
Ryan Halsted
Gilmartin Group
investors@ontrakhealth.com

Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announced significant findings from the first two-quarters of data collected through its implementation of the Recovering Quality of Life (ReQoL) measure. This patient-reported outcome measure (PROM) assesses the quality of life for individuals with various mental health conditions.

The ReQoL assessment, now a standard component of Ontrak's clinical model, has provided valuable insights into factors impacting mental health across diverse populations. ReQoL assessments are intended to evaluate the impact of mental health conditions, psychological interventions, and healthcare interventions on members’ lives because they focus on understanding the person over the diagnosis, consistent with modern recovery-oriented strategies. Integrating this tool in Ontrak's WholeHealth+ program emphasizes the commitment to measurement feedback in continually improving mental health care and outcomes.

Key Findings:

1. Prevalence of Poor Quality of Life: Results from baseline assessments of adults 18 years and older enrolled in the WholeHealth+ program reveal that 58% of the Medicaid population and 29% of the Commercial population report a poorer quality of life as compared to the general population.
2. Significant Improvements Observed: Ontrak's analysis shows that 35% of Medicaid and 18% of Commercial members who completed subsequent assessments have already significantly improved their ReQoL scores (defined as an increase of 5 or more points) in follow-up surveys during the two quarters collected since launch. Ontrak's advanced engagement system and continuous measurement feedback loop ensure that members receive timely, targeted support, contributing to these positive outcomes. This positive trend aligns with the consistently demonstrated improvements in Depression and Anxiety as measured by PHQ-9 and GAD-7, which are also PROMs administered in the Ontrak WholeHealth+ program.

Dr. Judith Feld, MD, MPH, MMM, Chief Medical Officer at Ontrak Health, commented on the findings: "The ReQoL data results provide us with more nuanced insights into the mental health challenges faced by our members. The ReQoL measure has proven to be a powerful tool for uncovering hidden struggles and tracking clinical progress. Utilizing the ReQoL in our clinical programs has significantly improved the effectiveness of our tech-enabled personalized interventions.”

About Ontrak Health

Ontrak Health (Nasdaq: OTRK) is a leading AI and technology-enabled behavioral healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder, and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socioeconomic, medical, and health system barriers that exacerbate the severity of their comorbid illnesses. The company's integrated intervention platform uses AI, predictive analytics, and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240912747147/en/